Skip to main content
NCBI home page
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1990;88:727–796.

Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated disease.

D Pavan-Langston 1
PMCID: PMC1298604  PMID: 1965619

Full text

PDF
727

Images in this article

741FIGURE 2
on p.741
744FIGURE 3
on p.744
757FIGURE 4 Slot 1
on p.757
758FIGURE 4 Slot 2
on p.758
766FIGURE 5 A,B,C,D,E,F
on p.766
766FIGURE 5 F,G
on p.766
783FIGURE 9
on p.783

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abghari S. Z., Stulting R. D. Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice. Invest Ophthalmol Vis Sci. 1988 Feb;29(2):239–243. [PubMed] [Google Scholar]
  2. Abghari S. Z., Stulting R. D. Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice. Invest Ophthalmol Vis Sci. 1988 Feb;29(2):239–243. [PubMed] [Google Scholar]
  3. Acheson G. H. Tetraethylammonium, ganglionic blocking agents, and the development of antihypertensive therapy. Perspect Biol Med. 1975 Autumn;19(1):136–148. doi: 10.1353/pbm.1975.0050. [DOI] [PubMed] [Google Scholar]
  4. Bell D. M., Holman R. C., Pavan-Langston D. Herpes Simplex keratitis: epidemiologic aspects. Ann Ophthalmol. 1982 May;14(5):421-2, 424. [PubMed] [Google Scholar]
  5. Blyth W. A., Hill T. J., Field H. J., Harbour D. A. Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. J Gen Virol. 1976 Dec;33(3):547–550. doi: 10.1099/0022-1317-33-3-547. [DOI] [PubMed] [Google Scholar]
  6. Boisjoly H. M., Woog J. J., Pavan-Langston D., Park N. H. Prophylactic topical cyclosporine in experimental herpetic stromal keratitis. Arch Ophthalmol. 1984 Dec;102(12):1804–1807. doi: 10.1001/archopht.1984.01040031462023. [DOI] [PubMed] [Google Scholar]
  7. Brown P. C., Tlsty T. D., Schimke R. T. Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea. Mol Cell Biol. 1983 Jun;3(6):1097–1107. doi: 10.1128/mcb.3.6.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cabrera C. V., Wohlenberg C., Openshaw H., Rey-Mendez M., Puga A., Notkins A. L. Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature. 1980 Nov 20;288(5788):288–290. doi: 10.1038/288288a0. [DOI] [PubMed] [Google Scholar]
  9. Campbell R., Pavan-Langston D., Lass J., Berman M., Gage J., Albert D. Collagenase levels in a new model of experimental herpetic interstitial keratitis. Arch Ophthalmol. 1980 May;98(5):919–923. doi: 10.1001/archopht.1980.01020030913022. [DOI] [PubMed] [Google Scholar]
  10. Carroll J. M., Martola E. L., Laibson P. R., Dohlman C. H. The recurrence of herpetic keratitis following idoxuridine therapy. Am J Ophthalmol. 1967 Jan;63(1):103–107. doi: 10.1016/0002-9394(67)90583-1. [DOI] [PubMed] [Google Scholar]
  11. Claoué C. M., Blyth W. A., Hill T. J., Easty D. L. Does herpes simplex virus establish latency in the eye of the mouse? Eye (Lond) 1987;1(Pt 4):525–528. doi: 10.1038/eye.1987.79. [DOI] [PubMed] [Google Scholar]
  12. Collum L. M., Benedict-Smith A., Hillary I. B. Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration. Br J Ophthalmol. 1980 Oct;64(10):766–769. doi: 10.1136/bjo.64.10.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cook M. L., Bastone V. B., Stevens J. G. Evidence that neurons harbor latent herpes simplex virus. Infect Immun. 1974 May;9(5):946–951. doi: 10.1128/iai.9.5.946-951.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cook S. D., Aitken D. A., Loeffler K. U., Brown S. M. Herpes simplex virus in the cornea; an ultrastructural study on viral reactivation. Trans Ophthalmol Soc U K. 1986;105(Pt 6):634–641. [PubMed] [Google Scholar]
  15. Coster D. J. Treacher Collins Prize Essay, 1979. Inflammatory disease of the outer eye. Trans Ophthalmol Soc U K. 1979;99(4):463–480. [PubMed] [Google Scholar]
  16. Coupes D., Klapper P. E., Cleator G. M., Bailey A. S., Tullo A. B. Herpesvirus simplex in chronic human stromal keratitis. Curr Eye Res. 1986 Oct;5(10):735–738. doi: 10.3109/02713688609000013. [DOI] [PubMed] [Google Scholar]
  17. Croen K. D., Ostrove J. M., Dragovic L. J., Smialek J. E., Straus S. E. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization. N Engl J Med. 1987 Dec 3;317(23):1427–1432. doi: 10.1056/NEJM198712033172302. [DOI] [PubMed] [Google Scholar]
  18. Dawson C., Togni B., Moore T. E., Jr Structural changes in chronic herpetic keratitis. Studied by light and electron microscopy. Arch Ophthalmol. 1968 Jun;79(6):740–747. doi: 10.1001/archopht.1968.03850040742016. [DOI] [PubMed] [Google Scholar]
  19. Dunkel E. C., Green M. T., Rosborough J. P. Suppression of HSV-1 infection in trigeminal ganglion cells. An in vitro model of latency. Invest Ophthalmol Vis Sci. 1984 May;25(5):525–533. [PubMed] [Google Scholar]
  20. Dunkel E. C., Pavan-Langston D. HSV-induced reactivation: contribution of epinephrine after corneal iontophoresis. Curr Eye Res. 1987 Jan;6(1):75–84. doi: 10.3109/02713688709020072. [DOI] [PubMed] [Google Scholar]
  21. Easty D. L., Shimeld C., Claoue C. M., Menage M. Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr Eye Res. 1987 Jan;6(1):69–74. doi: 10.3109/02713688709020071. [DOI] [PubMed] [Google Scholar]
  22. Fraser N. W., Lawrence W. C., Wroblewska Z., Gilden D. H., Koprowski H. Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6461–6465. doi: 10.1073/pnas.78.10.6461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fukuda J., Kurata T., Yamaguchi K. Specific reduction in Na currents after infection with herpes simplex virus in cultured mammalian nerve cells. Brain Res. 1983 Jun 6;268(2):367–371. doi: 10.1016/0006-8993(83)90506-1. [DOI] [PubMed] [Google Scholar]
  24. Gadler H., Larsson A., Sølver E. Nucleic acid hybridization, a method to determine effects of antiviral compounds on herpes simplex virus type 1 DNA synthesis. Antiviral Res. 1984 Apr;4(1-2):63–70. doi: 10.1016/0166-3542(84)90026-3. [DOI] [PubMed] [Google Scholar]
  25. Gadler H. Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replication. Antimicrob Agents Chemother. 1983 Sep;24(3):370–374. doi: 10.1128/aac.24.3.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Galloway D. A., Copple C. D., McDougall J. K. Analysis of viral DNA sequences in hamster cells transformed by herpes simplex virus type 2. Proc Natl Acad Sci U S A. 1980 Feb;77(2):880–884. doi: 10.1073/pnas.77.2.880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Galloway D. A., Fenoglio C. M., McDougall J. K. Limited transcription of the herpes simplex virus genome when latent in human sensory ganglia. J Virol. 1982 Feb;41(2):686–691. doi: 10.1128/jvi.41.2.686-691.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gelb L. D., Kohne D. E., Martin M. A. Quantitation of Simian virus 40 sequences in African green monkey, mouse and virus-transformed cell genomes. J Mol Biol. 1971 Apr 14;57(1):129–145. doi: 10.1016/0022-2836(71)90123-9. [DOI] [PubMed] [Google Scholar]
  29. Gordon Y. J., Armstrong J. A., Brown S. I., Becker Y. The role of herpesvirus type 1 thymidine kinase in experimental ocular infections. Am J Ophthalmol. 1983 Feb;95(2):175–181. doi: 10.1016/0002-9394(83)90011-9. [DOI] [PubMed] [Google Scholar]
  30. Gordon Y. J., Gilden D. M., Becker Y. HSV-1 thymidine kinase promotes virulence and latency in the mouse. Invest Ophthalmol Vis Sci. 1983 May;24(5):599–602. [PubMed] [Google Scholar]
  31. Gordon Y. J., Johnson B., Romanowski E., Araullo-Cruz T. RNA complementary to herpes simplex virus type 1 ICP0 gene demonstrated in neurons of human trigeminal ganglia. J Virol. 1988 May;62(5):1832–1835. doi: 10.1128/jvi.62.5.1832-1835.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Green M. T., Courtney R. J., Dunkel E. C. Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals. Infect Immun. 1981 Dec;34(3):987–992. doi: 10.1128/iai.34.3.987-992.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Green M. T., Dunkel E. C., Courtney R. J. Detection of herpes simplex virus induced polypeptides in rabbit trigeminal ganglia. Invest Ophthalmol Vis Sci. 1984 Dec;25(12):1436–1440. [PubMed] [Google Scholar]
  34. Green M. T., Dunkel E. C., Pavan-Langston D. Effect of immunization and immunosuppression on induced ocular shedding and recovery of herpes simplex virus in infected rabbits. Exp Eye Res. 1987 Sep;45(3):375–383. doi: 10.1016/s0014-4835(87)80124-0. [DOI] [PubMed] [Google Scholar]
  35. Green M. T., Dunkel E. C. Quantitation of herpes simplex virus in vitro and in preocular tear film. Invest Ophthalmol Vis Sci. 1981 Dec;21(6):882–886. [PubMed] [Google Scholar]
  36. Green M. T., Dunkel E. C. Quantitation of herpes simplex virus in vitro and in preocular tear film. Invest Ophthalmol Vis Sci. 1981 Dec;21(6):882–886. [PubMed] [Google Scholar]
  37. Green M. T., Knesek J. E., Dunkel E. C., SeGall G. K. Localization of 3H-thymidine-labeled HSV-1 in latently infected rabbit trigeminal ganglion cells. Invest Ophthalmol Vis Sci. 1987 Feb;28(2):394–397. [PubMed] [Google Scholar]
  38. Green M. T., Rosborough J. P., Dunkel E. C. In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: electrode model. Infect Immun. 1981 Oct;34(1):69–74. doi: 10.1128/iai.34.1.69-74.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Gyllensten U. B., Erlich H. A. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7652–7656. doi: 10.1073/pnas.85.20.7652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Hill J. M., Kwon B. S., Shimomura Y., Colborn G. L., Yaghmai F., Gangarosa L. P. Herpes simplex virus recovery in neural tissues after ocular HSV shedding induced by epinephrine iontophoresis to the rabbit cornea. Invest Ophthalmol Vis Sci. 1983 Feb;24(2):243–247. [PubMed] [Google Scholar]
  41. Hill T. J., Blyth W. A. An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins. Lancet. 1976 Feb 21;1(7956):397–399. doi: 10.1016/s0140-6736(76)90220-8. [DOI] [PubMed] [Google Scholar]
  42. Hill T. J., Blyth W. A., Harbour D. A. Trauma to the skin causes recurrence of herpes simplex in the mouse. J Gen Virol. 1978 Apr;39(1):21–28. doi: 10.1099/0022-1317-39-1-21. [DOI] [PubMed] [Google Scholar]
  43. Hollyfield J. G., Rayborn M. E., Sarthy P. V., Lam D. M. The emergence, localization and maturation of neurotransmitter systems during development of the retina in Xenopus laevis. I. Gamma aminobutyric acid. J Comp Neurol. 1979 Dec 15;188(4):587–598. doi: 10.1002/cne.901880406. [DOI] [PubMed] [Google Scholar]
  44. Honess R. W., Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol. 1974 Jul;14(1):8–19. doi: 10.1128/jvi.14.1.8-19.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hoyt C. S., Billson F. A. Herpes-simplex infection after blow-out fractures. Lancet. 1976 Dec 18;2(7999):1364–1365. doi: 10.1016/s0140-6736(76)92024-9. [DOI] [PubMed] [Google Scholar]
  46. Imperia P. S., Lazarus H. M., Dunkel E. C., Pavan-Langston D., Geary P. A., Lass J. H. An in vitro study of ophthalmic antiviral agent toxicity on rabbit corneal epithelium. Antiviral Res. 1988 Jul;9(4):263–272. doi: 10.1016/0166-3542(88)90057-5. [DOI] [PubMed] [Google Scholar]
  47. Kafatos F. C., Jones C. W., Efstratiadis A. Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucleic Acids Res. 1979 Nov 24;7(6):1541–1552. doi: 10.1093/nar/7.6.1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Kaufman H. E. Editorial: Herpetic stromal disease. Am J Ophthalmol. 1975 Dec;80(6):1092–1094. doi: 10.1016/0002-9394(75)90343-8. [DOI] [PubMed] [Google Scholar]
  49. Kaufman H. E., Varnell E. D., Centifanto-Fitzgerald Y. M., De Clercq E., Kissling G. E. Oral antiviral drugs in experimental herpes simplex keratitis. Antimicrob Agents Chemother. 1983 Dec;24(6):888–891. doi: 10.1128/aac.24.6.888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Klein R. J. Initiation and maintenance of latent herpes simplex virus infections: the paradox of perpetual immobility and continuous movement. Rev Infect Dis. 1985 Jan-Feb;7(1):21–30. doi: 10.1093/clinids/7.1.21. [DOI] [PubMed] [Google Scholar]
  51. Klein R. J. Pathogenetic mechansims of recurrent herpes simplex virus infections. Arch Virol. 1976;51(1-2):1–13. doi: 10.1007/BF01317829. [DOI] [PubMed] [Google Scholar]
  52. Klein R. J. Problems of herpes simplex virus latency. Antiviral Res. 1985;Suppl 1:111–120. doi: 10.1016/s0166-3542(85)80017-6. [DOI] [PubMed] [Google Scholar]
  53. Kristensson K., Ghetti B., Wiśniewski H. M. Study on the propagation of Herpes simplex virus (type 2) into the brain after intraocular injection. Brain Res. 1974 Apr 5;69(2):189–201. doi: 10.1016/0006-8993(74)90001-8. [DOI] [PubMed] [Google Scholar]
  54. Kudler L., Jones T. R., Russell R. J., Hyman R. W. Heteroduplex analysis of cloned fragments of herpes simplex virus DNAs. Virology. 1983 Jan 15;124(1):86–99. doi: 10.1016/0042-6822(83)90292-1. [DOI] [PubMed] [Google Scholar]
  55. Langston D. P., Dunkel E. C. A rapid clinical diagnostic test for herpes simplex infectious keratitis. Am J Ophthalmol. 1989 Jun 15;107(6):675–677. doi: 10.1016/0002-9394(89)90269-9. [DOI] [PubMed] [Google Scholar]
  56. Lass J. H., Pavan-Langston D., Park N. H. Aciclovir and corneal wound healing. Am J Ophthalmol. 1979 Jul;88(1):102–108. doi: 10.1016/0002-9394(79)90762-1. [DOI] [PubMed] [Google Scholar]
  57. Maudgal P. C., De Clercq E., Missotten L. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections. Antiviral Res. 1984 Oct;4(5):281–291. doi: 10.1016/0166-3542(84)90033-0. [DOI] [PubMed] [Google Scholar]
  58. McKnight S. L. The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res. 1980 Dec 20;8(24):5949–5964. doi: 10.1093/nar/8.24.5949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Meyers-Elliott R. H., Pettit T. H., Maxwell W. A. Viral antigens in the immune ring of Herpes simplex stromal keratitis. Arch Ophthalmol. 1980 May;98(5):897–904. doi: 10.1001/archopht.1980.01020030891018. [DOI] [PubMed] [Google Scholar]
  60. Meyers R. L., Chitjian P. A. Immunology of herpesvirus infection: immunity to herpes simplex virus in eye infections. Surv Ophthalmol. 1976 Sep-Oct;21(2):194–204. doi: 10.1016/0039-6257(76)90100-4. [DOI] [PubMed] [Google Scholar]
  61. Meyers R. L., Pettit T. H. Corneal immune response to Herpes simplex virus antigens. J Immunol. 1973 Jun;110(6):1575–1590. [PubMed] [Google Scholar]
  62. Mullis K. B., Faloona F. A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987;155:335–350. doi: 10.1016/0076-6879(87)55023-6. [DOI] [PubMed] [Google Scholar]
  63. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. II. N Engl J Med. 1973 Oct 4;289(14):719–725. doi: 10.1056/NEJM197310042891404. [DOI] [PubMed] [Google Scholar]
  64. Nesburn A. B., Dickinson R., Radnoti M., Green M. J. Experimental reactivation of ocular herpes simplex in rabbits. Surv Ophthalmol. 1976 Sep-Oct;21(2):185–190. doi: 10.1016/0039-6257(76)90098-9. [DOI] [PubMed] [Google Scholar]
  65. Nesburn A. B., Elliott J. H., Leibowitz H. M. Spontaneous reactivation of experimental herpes simplex keratitis in rabbits. Arch Ophthalmol. 1967 Oct;78(4):523–529. doi: 10.1001/archopht.1967.00980030525021. [DOI] [PubMed] [Google Scholar]
  66. Nesburn A. B., Green M. T. Editorial: Recurrence in ocular herpes simplex infection. Invest Ophthalmol. 1976 Jul;15(7):515–518. [PubMed] [Google Scholar]
  67. Nesburn A. B., Green M. T., Radnoti M., Walker B. Reliable in vivo model for latent herpes simplex virus reactivation with peripheral virus shedding. Infect Immun. 1977 Mar;15(3):772–775. doi: 10.1128/iai.15.3.772-775.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Nishiyama Y., Rapp F. Latency in vitro using irradiated herpes simplex virus. J Gen Virol. 1981 Jan;52(Pt 1):113–119. doi: 10.1099/0022-1317-52-1-113. [DOI] [PubMed] [Google Scholar]
  69. Openshaw H. Latency of herpes simplex virus in ocular tissue of mice. Infect Immun. 1983 Feb;39(2):960–962. doi: 10.1128/iai.39.2.960-962.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Park N. H., Pavan-Langston D., Boisjoly H. M., De Clercq E. Chemotherapeutic efficacy of E-5-(2-bromovinyl)-2'deoxyuridine for orofacial infection with herpes simplex virus type 1 in mice. J Infect Dis. 1982 Jun;145(6):909–913. doi: 10.1093/infdis/145.6.909. [DOI] [PubMed] [Google Scholar]
  71. Park N. H., Pavan-Langston D., Declercq E. Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes simplex virus in vitro. Am J Med. 1982 Jul 20;73(1A):151–154. doi: 10.1016/0002-9343(82)90081-x. [DOI] [PubMed] [Google Scholar]
  72. Park N. H., Pavan-Langston D., Hettinger M. E. Acyclovir therapy for the orofacial and ganglionic HSV infection in hairless mice. J Dent Res. 1980 Dec;59(12):2080–2086. doi: 10.1177/00220345800590121101. [DOI] [PubMed] [Google Scholar]
  73. Park N. H., Pavan-Langston D., Hettinger M. E., McLean S. L., Albert D. M., Lin T. S., Prusoff W. H. Topical therapeutic efficacy of 9-(2-hydroxyethoxymethyl)guanine and 5-iodo-5'-amino-2',5'-dideoxyuridine on oral infection with herpes simplex virus in mice. J Infect Dis. 1980 May;141(5):575–579. doi: 10.1093/infdis/141.5.575. [DOI] [PubMed] [Google Scholar]
  74. Park N. H., Pavan-Langston D., McLean S. L. Acylovir in oral and ganglionic herpes simplex virus infections. J Infect Dis. 1979 Nov;140(5):802–806. doi: 10.1093/infdis/140.5.802. [DOI] [PubMed] [Google Scholar]
  75. Park N. H., Pavan-Langston D., McLean S. L., Albert D. M. Therapy of experimental herpes simplex encephalitis with aciclovir in mice. Antimicrob Agents Chemother. 1979 Jun;15(6):775–779. doi: 10.1128/aac.15.6.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Pavan-Langston D., Campbell R., Lass J. Acyclic antimetabolite therapy of experimental herpes simplex keratitis. Am J Ophthalmol. 1978 Nov;86(5):618–623. doi: 10.1016/0002-9394(78)90178-2. [DOI] [PubMed] [Google Scholar]
  77. Pavan-Langston D. Clinical evaluation of adenine arabinoside and idoxuridine in the treatment of ocular herpes simplex. Am J Ophthalmol. 1975 Sep;80(3 Pt 2):495–502. doi: 10.1016/0002-9394(75)90214-7. [DOI] [PubMed] [Google Scholar]
  78. Pavan-Langston D., Foster C. S. Trifluorothymidine and idoxuridine therapy of ocular herpes. Am J Ophthalmol. 1977 Dec;84(6):818–825. doi: 10.1016/0002-9394(77)90504-9. [DOI] [PubMed] [Google Scholar]
  79. Pavan-Langston D., Foster C. S. Trifluorothymidine and idoxuridine therapy of ocular herpes. Am J Ophthalmol. 1977 Dec;84(6):818–825. doi: 10.1016/0002-9394(77)90504-9. [DOI] [PubMed] [Google Scholar]
  80. Pavan-Langston D., Lass J., Campbell R. Antiviral drops: comparative therapy of experimental herpes simplex keratouveitis. Arch Ophthalmol. 1979 Jun;97(6):1132–1135. doi: 10.1001/archopht.1979.01020010586017. [DOI] [PubMed] [Google Scholar]
  81. Pavan-Langston D., Nelson D. J. Intraocular penetration of trifluridine. Am J Ophthalmol. 1979 Jun;87(6):814–818. doi: 10.1016/0002-9394(79)90360-x. [DOI] [PubMed] [Google Scholar]
  82. Pavan-Langston D., Nesburn A. B. The chronology of primary herpes simplex infection of the eye and adnexal glands. Arch Ophthalmol. 1968 Aug;80(2):258–264. doi: 10.1001/archopht.1968.00980050260021. [DOI] [PubMed] [Google Scholar]
  83. Pavan-Langston D., Park N. H., Lass J. H. Herpetic ganglionic latency. Aciclovir and vidarabine therapy. Arch Ophthalmol. 1979 Aug;97(8):1508–1510. doi: 10.1001/archopht.1979.01020020170017. [DOI] [PubMed] [Google Scholar]
  84. Pavan-Langston D., Park N. H., Lass J., Papale J., Albert D. M., Lin T., Prusoff W. H., Percy D. H. 5'-amino-5'-deoxythymidine: topical therapeutic efficacy in ocular herpes and systemic teratogenic and toxicity studies. Proc Soc Exp Biol Med. 1982 May;170(1):1–7. doi: 10.3181/00379727-170-41386. [DOI] [PubMed] [Google Scholar]
  85. Pavan-Langston D., Rong B. L., Dunkel E. C. Extraneuronal herpetic latency: animal and human corneal studies. Acta Ophthalmol Suppl. 1989;192:135–141. doi: 10.1111/j.1755-3768.1989.tb07104.x. [DOI] [PubMed] [Google Scholar]
  86. Peden K., Mounts P., Hayward G. S. Homology between mammalian cell DNA sequences and human herpesvirus genomes detected by a hybridization procedure with high-complexity probe. Cell. 1982 Nov;31(1):71–80. doi: 10.1016/0092-8674(82)90406-8. [DOI] [PubMed] [Google Scholar]
  87. Pellicer A., Wigler M., Axel R., Silverstein S. The transfer and stable integration of the HSV thymidine kinase gene into mouse cells. Cell. 1978 May;14(1):133–141. doi: 10.1016/0092-8674(78)90308-2. [DOI] [PubMed] [Google Scholar]
  88. Price R. W., Khan A. Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity. Infect Immun. 1981 Nov;34(2):571–580. doi: 10.1128/iai.34.2.571-580.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Prusoff W. H., Ward D. C. Nucleoside analogs with antiviral activity. Biochem Pharmacol. 1976 Jun 1;25(11):1233–1239. doi: 10.1016/0006-2952(76)90083-6. [DOI] [PubMed] [Google Scholar]
  90. Puga A., Cantin E. M., Wohlenberg C., Openshaw H., Notkins A. L. Different sizes of restriction endonuclease fragments from the terminal repetitions of the herpes simplex virus type 1 genome latent in trigeminal ganglia of mice. J Gen Virol. 1984 Feb;65(Pt 2):437–444. doi: 10.1099/0022-1317-65-2-437. [DOI] [PubMed] [Google Scholar]
  91. Rabin E. R., Jenson A. B., Melnick J. L. Herpes simplex virus in mice: electron microscopy of neural spread. Science. 1968 Oct 4;162(3849):126–127. doi: 10.1126/science.162.3849.126. [DOI] [PubMed] [Google Scholar]
  92. Rigby P. W., Dieckmann M., Rhodes C., Berg P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol. 1977 Jun 15;113(1):237–251. doi: 10.1016/0022-2836(77)90052-3. [DOI] [PubMed] [Google Scholar]
  93. Rock D. L., Nesburn A. B., Ghiasi H., Ong J., Lewis T. L., Lokensgard J. R., Wechsler S. L. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J Virol. 1987 Dec;61(12):3820–3826. doi: 10.1128/jvi.61.12.3820-3826.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Roizman B. Herpesviruses, latency and cancer: a biochemical approach. J Reticuloendothel Soc. 1974 Apr;15(4):312–321. [PubMed] [Google Scholar]
  95. Rong B. L., Dunkel E. C., Pavan-Langston D. Molecular analysis of acyclovir-induced suppression of HSV-1 replication in rabbit corneal cells. Invest Ophthalmol Vis Sci. 1988 Jun;29(6):928–932. [PubMed] [Google Scholar]
  96. Sabbaga E. M., Pavan-Langston D., Bean K. M., Dunkel E. C. Detection of HSV nucleic acid sequences in the cornea during acute and latent ocular disease. Exp Eye Res. 1988 Oct;47(4):545–553. doi: 10.1016/0014-4835(88)90093-0. [DOI] [PubMed] [Google Scholar]
  97. Sabin A. B. Editorial: Misery of recurrent herpes: what to do? N Engl J Med. 1975 Nov 6;293(19):986–988. doi: 10.1056/NEJM197511062931908. [DOI] [PubMed] [Google Scholar]
  98. Sacks W. R., Schaffer P. A. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol. 1987 Mar;61(3):829–839. doi: 10.1128/jvi.61.3.829-839.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  100. Scriba M. Extraneural localisation of herpes simplex virus in latently infected guinea pigs. Nature. 1977 Jun 9;267(5611):529–531. doi: 10.1038/267529a0. [DOI] [PubMed] [Google Scholar]
  101. Severin M. J., White R. J. The neural transmission of herpes simplex virus in mice. Light and electron microscopic findings. Am J Pathol. 1968 Dec;53(6):1009–1020. [PMC free article] [PubMed] [Google Scholar]
  102. Shannon W. M., Westbrook L., Arnett G., Daluge S., Lee H., Vince R. Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice. Antimicrob Agents Chemother. 1983 Oct;24(4):538–543. doi: 10.1128/aac.24.4.538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Shimeld C., Tullo A. B., Easty D. L., Thomsitt J. Isolation of herpes simplex virus from the cornea in chronic stromal keratitis. Br J Ophthalmol. 1982 Oct;66(10):643–647. doi: 10.1136/bjo.66.10.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Shuster J. J., Kaufman H. E., Nesburn A. B. Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease. Am J Ophthalmol. 1981 Mar;91(3):328–331. doi: 10.1016/0002-9394(81)90285-3. [DOI] [PubMed] [Google Scholar]
  105. Spivack J. G., Fraser N. W. Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J Virol. 1987 Dec;61(12):3841–3847. doi: 10.1128/jvi.61.12.3841-3847.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Steiner I., Spivack J. G., Lirette R. P., Brown S. M., MacLean A. R., Subak-Sharpe J. H., Fraser N. W. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J. 1989 Feb;8(2):505–511. doi: 10.1002/j.1460-2075.1989.tb03404.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Stevens J. G., Cook M. L. Latent herpes simplex virus in spinal ganglia of mice. Science. 1971 Aug 27;173(3999):843–845. doi: 10.1126/science.173.3999.843. [DOI] [PubMed] [Google Scholar]
  108. Stevens J. G. Defining herpes simplex genes involved in neurovirulence and neuroinvasiveness. Curr Eye Res. 1987 Jan;6(1):63–67. doi: 10.3109/02713688709020070. [DOI] [PubMed] [Google Scholar]
  109. Stevens J. G., Wagner E. K., Devi-Rao G. B., Cook M. L., Feldman L. T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science. 1987 Feb 27;235(4792):1056–1059. doi: 10.1126/science.2434993. [DOI] [PubMed] [Google Scholar]
  110. Straus S. E., Takiff H. E., Seidlin M., Bachrach S., Lininger L., DiGiovanna J. J., Western K. A., Smith H. A., Lehrman S. N., Creagh-Kirk T. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med. 1984 Jun 14;310(24):1545–1550. doi: 10.1056/NEJM198406143102401. [DOI] [PubMed] [Google Scholar]
  111. Tenser R. B., Dawson M., Ressel S. J., Dunstan M. E. Detection of herpes simplex virus mRNA in latently infected trigeminal ganglion neurons by in situ hybridization. Ann Neurol. 1982 Mar;11(3):285–291. doi: 10.1002/ana.410110309. [DOI] [PubMed] [Google Scholar]
  112. Tenser R. B., Dunstan M. E. Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion. Virology. 1979 Dec;99(2):417–422. doi: 10.1016/0042-6822(79)90021-7. [DOI] [PubMed] [Google Scholar]
  113. Trousdale M. D., Dunkel E. C., Nesburn A. B. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit. Invest Ophthalmol Vis Sci. 1980 Nov;19(11):1336–1341. [PubMed] [Google Scholar]
  114. Trousdale M. D., Nesburn A. B., Willey D. E., Taaid H. Efficacy of BW759 (9-[[2-hydroxy-1(hydroxymethyl)ethoxy]methyl]guanine) against herpes simplex virus type 1 keratitis in rabbits. Curr Eye Res. 1984 Aug;3(8):1007–1015. doi: 10.3109/02713688409011747. [DOI] [PubMed] [Google Scholar]
  115. Tullo A. B., Easty D. L., Shimeld C., Stirling P. E., Darville J. M. Isolation of herpes simplex virus from corneal discs of patients with chronic stromal keratitis. Trans Ophthalmol Soc U K. 1985;104(Pt 2):159–165. [PubMed] [Google Scholar]
  116. Wagner E. K., Devi-Rao G., Feldman L. T., Dobson A. T., Zhang Y. F., Flanagan W. M., Stevens J. G. Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J Virol. 1988 Apr;62(4):1194–1202. doi: 10.1128/jvi.62.4.1194-1202.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Wagner E. K., Devi-Rao G., Feldman L. T., Dobson A. T., Zhang Y. F., Flanagan W. M., Stevens J. G. Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J Virol. 1988 Apr;62(4):1194–1202. doi: 10.1128/jvi.62.4.1194-1202.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Walz M. A., Yamamoto H., Notkins A. L. Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature. 1976 Dec 9;264(5586):554–556. doi: 10.1038/264554a0. [DOI] [PubMed] [Google Scholar]
  119. Wechsler S. L., Nesburn A. B., Watson R., Slanina S., Ghiasi H. Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J Gen Virol. 1988 Dec;69(Pt 12):3101–3106. doi: 10.1099/0022-1317-69-12-3101. [DOI] [PubMed] [Google Scholar]
  120. Whitcher J. P., Dawson C. R., Hoshiwara I., Daghfous T., Messadi M., Triki F., Oh J. O. Herpes simplex keratitis in a developing country. Natural history and treatment of epithelial ulcers in Tunisia. Arch Ophthalmol. 1976 Apr;94(4):587–592. doi: 10.1001/archopht.1976.03910030279006. [DOI] [PubMed] [Google Scholar]
  121. Whitley R., Lakeman A. D., Nahmias A., Roizman B. Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982 Oct 21;307(17):1060–1062. doi: 10.1056/NEJM198210213071706. [DOI] [PubMed] [Google Scholar]
  122. Wigdahl B., Rong B. L., Kinney-Thomas E. Varicella-zoster virus infection of human sensory neurons. Virology. 1986 Jul 30;152(2):384–399. doi: 10.1016/0042-6822(86)90141-8. [DOI] [PubMed] [Google Scholar]
  123. Wigler M., Sweet R., Sim G. K., Wold B., Pellicer A., Lacy E., Maniatis T., Silverstein S., Axel R. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell. 1979 Apr;16(4):777–785. doi: 10.1016/0092-8674(79)90093-x. [DOI] [PubMed] [Google Scholar]
  124. Wilhelmus K. R., Coster D. J., Jones B. R. Acyclovir and debridement in the treatment of ulcerative herpetic keratitis. Am J Ophthalmol. 1981 Mar;91(3):323–327. doi: 10.1016/0002-9394(81)90284-1. [DOI] [PubMed] [Google Scholar]
  125. Wylie B. A., Thomson J. A., Schoub B. D. Identification of five new variable restriction sites in HSV-1 DNA. S Afr Med J. 1985 Jul 20;68(2):98–102. [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES